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Hydrogen deuterium exchange mass spectrometry (HDX-MS) is a powerful technique that can provide insights into protein behavior by serving as a link between structure, conforma-
tional dynamics and function1. HDX-MS measures changes in mass 
associated with the isotopic exchange between amide hydrogens 
of the protein backbone and its surrounding solvent. The rate of 
this exchange is dependent on the folded state of the protein and its 
dynamics (particularly the stability of hydrogen bonding networks) 
and the intrinsic chemical properties of the underlying amino acid 
sequence2–4. HDX-MS is a very versatile technique5 and can be used 
to examine conformations of individual proteins or large protein 
complexes6, locate protein sites directly or indirectly involved in 
binding7, probe for allosteric effects8, monitor the folding dynam-
ics of protein domains9, examine intrinsic disorder10 and provide 
insights into protein–membrane interactions11. Of particular rel-
evance in industry, HDX-MS also excels at epitope mapping and the 
characterization of biotherapeutics12,13.
Measurement of protein HDX dates back to the 1950s14,15, with 
much of the work in the 1970–1980s using NMR spectroscopy as 
the method of detection16. Mass spectrometry has been the method 
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Hydrogen deuterium exchange mass spectrometry (HDX-MS) is a powerful biophysical technique being increasingly applied to 
a wide variety of problems. As the HDX-MS community continues to grow, adoption of best practices in data collection, analysis, 
presentation and interpretation will greatly enhance the accessibility of this technique to nonspecialists. Here we provide rec-
ommendations arising from community discussions emerging out of the first International Conference on Hydrogen-Exchange 
Mass Spectrometry (IC-HDX; 2017). It is meant to represent both a consensus viewpoint and an opportunity to stimulate fur-
ther additions and refinements as the field advances.
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of choice for detecting HDX since the 1990s17,18, because it can 
accommodate large proteins (>100 kDa), accept low concentrations 
(less than micromolar) and tolerate complex sample matrices19. 
Additional advances in liquid chromatography (LC)-MS technology 
and automation have greatly increased the user base for HDX-MS. 
Data analysis software has progressed markedly20–22, increasing 
processing speeds by several orders of magnitude over the past ten 
years. The analysis of large multi-subunit proteins no longer takes 
weeks or months. A reduced barrier to entry has accompanied these 
developments, resulting in an explosion in the amount of HDX-MS 
data being generated. It is not surprising that the number and diver-
sity of studies that use some variant of the HDX-MS method is 
increasing year over year23–33 (Fig. 1).
Producing a deuterium-labeled sample is simple and requires 
no specialized equipment or chemicals, other than D2O. However, 
the labeling reaction is highly sensitive to experimental conditions, 
such as pH and temperature fluctuations, among other factors34. 
It requires a number of controls and a great amount of care to ensure 
that the reaction is conducted in a manner that does not bias the 
results or lead to imprecise measurements. If properly performed, 
the HDX-MS method is very reproducible7,35,36, but repeated HDX 
reactions must be conducted to assess the degree of variability 
caused by external factors. When due care and attention is taken to 
fully account for all aspects of sample production37, HDX-MS pro-
vides reliable insights into protein structure–function properties.
HDX-MS data complement other structural biology techniques, 
such as nuclear magnetic resonance (NMR) spectroscopy38, electron 
microscopy30,39, native mass spectrometry40,41, molecular dynamics 
simulation42 and X-ray crystallography43,44, and are often presented 
alongside these techniques to nonspecialist reviewers. Likewise, 
scientists who primarily focus on these complementary techniques 
may, given the attractiveness and accessibility of HDX-MS, choose 
to embark on HDX-MS experiments themselves. Unfortunately, the 
simplicity of the experiment does not always translate into simplicity 
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Fig. 1 | The wide range of applications for HDX-MS in many protein-folding studies. Clockwise from top left: Hamdi et al.24 localized dehydration and 
zinc-activated disorder-to-order transitions in abiotic plant stress response proteins using HDX-MS. Baños-Mateos et al.25 demonstrated how HDX-MS 
can be used in combination with X-ray crystallography and cryo-electron microscopy (cryo-EM) when determining the mechanism of exonuclease activity 
of DnaE1. Lim et al.26 determined how an increase in temperature alters the Dengue virus capsid structure, resulting in an alteration in antibody-binding 
mode. Using ETD-HDX/MS/MS, Masson et al.27 discerned the basis of isotype specificity of pharmaceutical compounds by determining single-residue 
exchange rates. Merkle et al.28 localized the substrate-dependent partial unwinding of transmembrane helices, which facilities substrate translocation 
using HDX-MS. Lee et al.29 revealed a new allosteric mechanism for interrupting the antiapoptotic binding of MCL-1 to BH3 domains, providing a new 
avenue for cancer therapy. Shukla et al.30 demonstrated how HDX-MS can provide mechanistic and dynamic detail to cryo-EM structures, and how 
HDX-MS can aid modeling of X-ray structures within the cryo-EM density. Adams et al.31 illustrated the utility of HDX-MS, used in conjunction with X-ray 
crystallography and biophysical methods, to reveal how the monoclonal antibody VHH6 contemporaneously interacts with IL-6 and gp80 through a 
junctional epitope. Rostislavleva et al.32 pushed the limits of HDX-MS with the large lipid kinase VPS34 complex II by both determining the membrane-
interacting regions of the lipid kinase and screening nanobodies to facilitate crystallization and subsequent structure determination. By altering the pH of 
the labelling solution, de Vera et al.33 observed interactions of disordered protein domain on a millisecond timescale by HDX-MS.
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of interpretation, as the exchange mechanism is complex and impor-
tant experimental information is all too often missing. Incomplete 
information compromises the ability to interpret published findings 
of others. To remedy this situation with several community-driven 
objectives, we aim to (1) develop consensus-based minimum rec-
ommendations for conducting HDX-MS experiments, along with 
the minimum information required for publication of HDX-MS 
data; (2) provide a resource for reviewers of manuscripts contain-
ing HDX-MS data, allowing them to assess the quality of presented 
data, and to assist editorial staff in establishing acceptable publica-
tion criteria; and (3) position the HDX-MS community for the cre-
ation of a standardized and curatable data format that allows for 
archiving datasets for meta-analysis and protein modeling.
Development of the recommendations
The recommendations outlined below were initially discussed in 
May of 2017 during the first International Conference of Hydrogen 
Deuterium Exchange (IC-HDX) in Gothenberg, Sweden. The many 
HDX-MS experts present at IC-HDX debated the minimum crite-
ria for HDX-MS experiments and manuscripts, and reached several 
consensus points. A draft document incorporating the primary ele-
ments of this debate was disseminated among the HDX-MS com-
munity, through discussion lists and through direct enquiries to 
experienced HDX-MS users who could not attend the meeting.
Scope of the recommendations
These recommendations are precisely that: recommendations. 
They represent community-endorsed practices that ensure mini-
mum requirements necessary to accurately conduct an HDX-MS 
experiment and report its results. Their aim is to be as practicable 
as possible to promote widespread adoption. Not all HDX-MS 
experiments need to conform to these recommendations, but in our 
opinion, any substantial deviation from these guidelines should be 
explained. Experiments that are purely technical, focusing on the 
minutiae of exchange behavior, or exchange under extreme con-
ditions may deviate substantially from the recommendations, but 
these experiments are likely to be conducted by those already expert 
in the technique, with an explanation of their reasoning for select-
ing these conditions.
We also recommend that newcomers to HDX-MS familiarize 
themselves with the theoretical basis of hydrogen exchange and 
how protein structure influences this phenomenon. An apprecia-
tion of this theoretical background is crucial for the interpretation 
of HDX-MS data, and much literature exists on the subject1,2,19.
Currently, the most widely used HDX-MS experimental format 
involves an in-solution labeling step followed by injection onto an 
immobilized protease column, desalting and separation of proteo-
lytic peptides using a cooled reversed-phase LC system and finally 
mass analysis conducted by a mass spectrometer (Fig. 2). This clas-
sical continuous-labeling, bottom-up or local HDX-MS17–19,45 exper-
iment is the focus of the current recommendations, but it is by no 
means the only HDX-MS experiment. In the future we may address 
other variations such as global HDX-MS analysis45, bottom-up or 
top-down HDX-MS/MS46–49 and gas-phase HDX-MS50. The two 
primary issues we wish to address for classical bottom-up HDX MS 
experiments are reproducibility and transparency.
Reproducibility. To produce quality studies, it is necessary to 
ensure that, given the same materials, instrumentation and proto-
col, the same observations would be made for any given experiment. 
This requirement impacts sample production, data acquisition 
and analysis.
Transparency. Data need to be more readily accessible to the com-
munity. These recommendations aim to create conduits to raw data, 
enabling further meta-analysis, providing increased confidence in 
reported observations and supporting ongoing software develop-
ment efforts.
If the recommendations are followed, we believe the end result 
will be an overall increase in the quality of published data and more 
meaningful scientific insights gleaned from the findings. These rec-
ommendations may require revision, enhancement and additions 
in the future as HDX-MS technology advances and evolves. At each 
future IC-HDX meeting, the current recommendations should be 
assessed, and altered or revised as necessary to keep pace with this 
fast-moving field.
 1. Sample preparation and analysis recommendations
1.1. We recommend that a sample quality assessment precede 
the HDX experiment. The assessment could include dena-
turing electrophoresis (SDS-PAGE) analysis and intact 
protein mass spectra to confirm sample purity and con-
firm the expected sequence and post-tranlational modici-
cations. A size-exclusion chromatography or native MS 
analysis is useful to establish the monomeric or oligo-
meric state of the sample being investigated, or a func-
tional biochemical assay to check that the protein is active 
and correctly folded.
1.2. We recommend a size-exclusion chromatography analysis 
to establish the monomeric/oligomeric state of the sample 
being investigated.
1.3. Sample preparation is key to a reliable HDX-MS experi-
ment. Given the sensitivity of HDX-MS, any perturbations 
in pH (or pD), temperature and ionic strength will have 
considerable effects on the outcome of any experiment, and 
so it is crucial to control these parameters. At a minimum, 
the buffer used in the labeling reaction must have sufficient 
buffering capacity to ensure a constant pH, and the tem-
perature of the labeling reaction must be well controlled. 
Therefore, the composition of the buffer used in the labeling 
reaction and the temperature and pHread (pH meter read-
ing with no isotope corrections applied) at which the reac-
tion was conducted must be reported. Both labeling buffer 
and protein solution must be pre-equilibrated at the tem-
perature of the ensuing HDX experiment and stably main-
tained during labeling.
1.4. The concentration of D2O (%, v/v) present during the labe-
ling reaction must be precisely maintained and clearly re-
ported. HDX experiments may be conducted with any con-
centration of D2O, but experiments are typically conducted 
at higher concentrations of D2O (80−90%), as this leads to 
greater deuterium incorporation (resulting in a larger mass 
shift). Achieving the highest signal-to-noise ratio (that 
is, sensitivity to distinguish differences in HDX between 
protein states) and minimizing spectral complexity can 
require optimizing the concentration of D2O used51, 
which should be precisely maintained throughout the ex-
periments and reported.
1.5. Quench buffer composition greatly affects the efficiency 
of digestion, and thus the protocol used for quenching 
should be reported (composition and pH of the quench 
buffer). The final composition of the quenched sample, 
that is, the concentration of labeled protein and quench 
solutions, as well as the pH of the quenched sample, 
should also be reported.
1.6. Repeated measurements of deuterium incorporation are 
necessary to ensure repeatability and deliver an estimate of 
the precision in the measurements. Independently gener-
ated exchange reactions serve as technical replicates. The 
same labeling reaction aliquoted and measured separately is 
not a suitable technical replicate, as this is not an independ-
ent observation. At a minimum, there should be at least 
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three labeling reaction experiments performed for at least 
one time point to allow a reasonable estimate of the error of 
measured deuterium levels. This estimate of error should be 
used to support the assignment of significance to differences 
in HDX between states. Labeling reactions (more than six) 
performed with extraction of many samples across a wide 
time range (more than four orders of magnitude) can pro-
vide additional confidence in the assignment of statistically 
significant differences in HDX. Where practical issues arise 
(for example, restricted sample supply), replicate measure-
ment may not be necessary for all the time points in the re-
ported HDX curves.
1.7. Biological replicates of the experiment should be con-
ducted where possible. This would require additional 
preparations of the protein. The repeats ensure that the 
variability in exchange measurements that can be as-
cribed to post-translational modifications/differences in 
protein expression/purification or variable stoichiome-
try in reconstituted protein complexes is quantified. Bi-
ological replicates are especially important for proteins 
that require extensive sample preparation before HDX-
MS (for example, nucleotide loading in monomeric 
GTPases52).
1.8. The LC-MS system used to collect the data should be made 
explicit in the methods section of the manuscript, along 
with pertinent instrument settings (for example, the LC 
gradient and flow rates, reversed-phase columns used, 
MS ion source parameters and so on).
1.9. As a variety of proteases are available for sample workup, 
the protease used in the experiment should be stated. 
Additionally, the duration of the digestion, the diges-
tion mode (off-line or on-line) and the temperature that 
the digestion was conducted under should be reported. 
In the case of on-line digestion, column dimensions, 
source and flow rate should be specified.
1.10. Evidence of LC-MS system suitability for reproducible 
deuterium recovery is required. The level of back-ex-
change (loss of deuterium) of the particular HDX-MS 
system and workflow being used must be characterized 
in detail by analysis of a mixture of model peptides (for 
example, bradykinin or angiotensin II) or ideally a di-
gest of a model protein (for example, hemoglobin, phos-
phorylase B or cytochrome c) that has been equilibrated 
in deuterated buffer for an extended time period (for 
example, 12 h) to allow complete labeling of all back-
bone amide NHs in the model peptide/protein. If such a
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Fig. 2 | The common ‘bottom-up’ or ‘local’ HDX-MS experiment. Proteins are incubated in deuterated buffer for a number of time points, allowing for 
the incorporation of deuterium into the protein backbone. The exchange reaction is quenched by a shift to acidic pH and a temperature drop (with the 
optional inclusion of denaturants and reducing agents to enhance protein unfolding). Proteins are then digested by an acid-functional protease, such as 
pepsin. The proteolytic peptides are desalted and separated using a chilled reversed-phase UHPLC system and eluted into a mass spectrometer, where 
they are ionized by electrospray and subjected to mass analysis to determine the increase in mass resulting from deuterium uptake. During spectral 
analysis, the isotopic envelopes of peptides are visualized, and levels of deuteration are determined, typically through comparison of the average mass 
from the intensity-weighted centroid m/z value (arrows) of the peptide. The example mass spectra show that the peptide has a deuterium level of 2.7 D. 
The deuterium uptake, resolved to individual peptide segments, is plotted across multiple time points. Peptide uptake plots reveal the local HDX profile of 
individual protein regions. Peptide uptake plots obtained in an identical manner for multiple states of the protein, such as folded and unfolded, or bound 
and unbound to a ligand, can be overlaid to enable quick comparison and detection of local differences in HDX (and conformation) between protein 
states. Such differences in HDX can then be mapped on a three-dimensional representation of the protein to facilitate structural interpretation. Structure 
adapted from Lee et al.58.
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characterization of the workflow and LC-MS system in 
use has been performed in an earlier study, that work can 
be referenced. The characterization serves to validate the 
workflow and LC-MS setup and ensures that a suitable lev-
el of deuterium is retained during any given experiment. 
The back-exchange of peptides of the model system used 
can be calculated using the following equation18,45,53:






= − −
×
×m m
N D
Back exchange 1 100100% 0%
frac
where m0% is the non-deuterated peptide centroid mass, 
m100% is the maximally labeled peptide centroid mass, N is 
the theoretical number of backbone amides in the peptide 
and Dfrac is the fraction of D/H in the labeling buffer used (for 
example, 0.80, 0.90, 0.95). Back-exchange levels are ideally 
reported on a per-peptide basis but may be reported as the 
average percentile loss of deuterium of all peptides analyzed 
with an indication of the range of values observed, for exam-
ple, 40% (ranging from 10% to 55%). In a well-conducted 
conventional state-of-the-art bottom-up HDX-MS work-
flow, only very few peptides should exhibit back-exchange 
values above 50%.
1.11.  We recommend producing a ‘maximally labeled’ control 
sample of the protein studied (also known as a 100% ex-
change control), particularly in situations where the absolute 
amount of exchange is desired. This control allows for an esti-
mate of the level of back-exchange for each analyzed peptide 
during sample work-up and analysis. A ‘quench exchange’ 
control sample may also be used to estimate the amount of 
on-exchange that occurs during the quench process, but 
unless long quench/digestion times (> min) or non-ideal 
quench conditions (pH > 2.5) are required, this is usually 
well-approximated by the non-deuterated centroid mass in 
a typical bottom-up LC-MS experiment. From this informa-
tion, a back-exchange corrected fractional deuterium level 
(Dcorr) can be estimated using the following equation:
= −
−
D
m m
m m
( )
( )corr
0%
100% 0%
where m is the observed peptide centroid mass at a given 
time-point, m0% is the non-deuterated peptide centroid mass 
and m100% is the maximally labeled peptide centroid mass. 
When Dcorr is expressed as a percentage value, it is sometimes 
referred to simply as the ‘back-exchange’ corrected percent-
age D value for a given analyzed peptide. A more explicit 
treatment can be found in ref. 53.
 The absolute amount of exchange (Dabsolute) in the peptide 
can then be calculated based on Dcorr as Dabsolute = Dcorr × 
N, where N is the theoretical number of backbone amides 
in the peptide. The absolute amount of exchange can be 
required for interpreting HDX-MS data in a structural 
context, for example, for identifying intrinsically disor-
dered regions. These controls are not strictly necessary for 
comparative measurements between different states of the 
same protein (for example, with and without ligand), as the 
back-exchange can reasonably be expected to be the same 
with each measurement. Furthermore, we recommend 
performing the labeling reaction that produces the maxi-
mally labeled control sample for 12−24 h at room tempera-
ture and low pH (2.5 < pH < 4) in the presence of a strong 
denaturant (for example, 6 M GndDCl or 6 M urea). Such 
a treatment usually offers adequate HDX equilibration be-
tween protein and labeling solution ensuring complete la-
beling of all backbone amide NHs. However, in rare cases, a 
maximally labeled control prepared in this manner can fail 
to exchange a minor subpopulation of very slow exchanging 
amide NHs, and furthermore sample aggregation can also 
be a concern for some proteins21. Preparation of maximally 
labeled control samples at higher pH values (pH > 5) and 
excessive labeling times (>24 h) or elevated temperatures 
(>25 °C) should be approached with caution, as histidine 
residues may, at these conditions, begin to incorporate a 
substantial amount of deuterium at the imidazole side-
chain (c-2 position), leading to higher than expected levels 
of deuterium54. In any case, a carefully prepared, maximally 
labeled control sample of the target protein under study 
will serve as the best possible estimate of the maximal level 
of deuterium one can expect to detect in each peptide ana-
lyzed during the given HDX-MS experiment.
1.12.  A wide range of D2O labeling times should be used to in-
terrogate the full range of possible amide exchange rates39. 
We recommend that labeling times span at least four or-
ders of magnitude (for example, 0.1 min, 1 min, 10 min, 
100 min and 1,000 min), with the shorter times in the 
range of 5−15 s, and the longer times lasting at least several 
hours. Importantly, sampling labeling times beyond four 
orders of magnitude can provide additional useful infor-
mation on HDX kinetics and error (see also recommenda-
tion 1.5). The exact time range will depend on the protein 
system in question. For example, experiments on intrinsi-
cally disordered proteins, which are likely to exhibit rapid 
HDX rates, can focus on even shorter labeling times (that 
is, 0.1 s, 1 s, 10 s or 100 s). For very stable proteins that 
may have extensive regions that undergo very slow HDX, 
experiments should be performed with very long labeling 
times (>1,000 min or 16 h). The selection of time points 
should be justified in the manuscript; it is important that 
the time points cover a range sufficient to allow for a sub-
stantial change in the deuterium level of the majority of 
the amides in a protein, while still allowing for the detec-
tion of fast exchange events. In short, the range should be 
targeted to the nature of the investigation, such as shorter 
labeling times with narrower time ranges for investigating 
transient molecular interactions or disordered proteins. 
Selecting the labeling times is particularly important when 
designing appropriate null hypothesis experiments for dif-
ferential HDX studies (that is, failing to disprove that there 
is no difference in HDX between two conditions).
1.13.  Especially for longer labeling times (for example, over 100 
min), we recommend conducting a quality control ‘deu-
terium-pulse’ experiment if the physical stability of the 
protein of study is unknown under labeling conditions. 
In such an experiment, the protein is incubated for a time 
equal to that of the longest labeling time but in the absence 
of deuterium and is then deuterium-labeled for a short 
time period (for example, 10−30 s). This pulse-labeled 
sample should then be compared to the sample from the 
equivalent short-labeling experiment but without the pri-
or incubation. The purpose of this comparison is to check 
whether the protein is undergoing structural changes (for 
example, precipitation, oligomerization or irreversible un-
folding) over the course of the labeling time, which may 
result in misinterpretation of data.
1.14.  To ensure optimal sensitivity for detecting changes in HDX 
during ligand-binding experiments, we recommend opti-
mizing ligand concentrations and ensuring adequate time 
for complex formation to ensure maximum protein occu-
pancy. Ligand and protein concentrations used during la-
beling should be stated, as well as the dissociation constant 
(if known).
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1.15.  In comparative HDX-MS analyses, we recommend follow-
ing good practices in experiment design to control variation. 
Analysis should be randomized. Our recommendation is to 
avoid collecting data for all states sequentially or collecting 
technical replicates sequentially for one state. By doing so, 
one can mitigate the effects of any drifts in instrument pa-
rameters, day-to-day variability (in case data are collected 
over multiple days), temperature fluctuations or any other 
parameter that might affect the HDX-MS experiment.
 2. Data analysis and data presentation guidelines
2.1. When conducting peptide identification using MS/MS, 
the spectral search database should include the sequence 
of all major proteins present in the sample and introduced 
during workup, to prevent false peptide identifications. 
This is especially advisable for complex sample types. The 
list should minimally include the proteases used and any 
major protein contaminants. The composition of the data-
base used for searching should be reported.
2.2. Peptide identification criteria should be included in the 
text, based on the search tool used (that is, scoring cut-off 
and its statistical basis). The name of the search software 
(and version) should be provided, with parameters appro-
priate for the mass spectrometer used.
2.3. For quality control purposes, the output of automated 
HDX-MS computational routines should be supported by 
an inspection of the raw data, including spectral assign-
ments and isotopologue detection. A summary of the HDX 
data should be reported in a table (for example, Table 1) 
with the following information for each protein included 
within the study: (1) HDX reaction details, for example, 
pH and temperature; (2) HDX time course, for example, 
what time points where analyzed; (3) number of peptides 
analyzed (that is, the total number of peptides for which 
the deuterium content has been analyzed in each dataset); 
(4) sequence coverage, expressed as a percentage of amides 
covered by the peptides for which deuterium content has 
been measured (rather than all peptides identified in the 
non-deuterated experiment); (5) average peptide length 
and redundancy; (6) a quantitative measure of the repeat-
ability of deuterium measurement, for instance, the aver-
age (mean, median, root-mean-square) standard deviation 
from replicate (technical or biological) measurements of 
the deuterium content of all or representative peptides from 
one or more time points; and (7) threshold for significant 
differences in HDX (a threshold value interpreted as repre-
senting a significant difference in HDX between examined 
protein states based on the quantitative measure of repeat-
ability. We recommend that such a table be provided in the 
supplementary material for all HDX manuscripts, similar to 
the convention in the X-ray crystallography field of report-
ing collection/refinement statistics55. We include an exam-
ple of the HDX summary table as a downloadable template 
spreadsheet (Supplementary Table 1) to encourage the com-
munity to include such data in their reporting, and to do so 
using a standardized and readily accessible format. We also 
recommend that a peptide coverage map—a figure show-
ing the identified peptides used to extract HDX information 
mapped onto the sequence of the protein studied—be in-
cluded in the manuscript or in the supplementary material.
2.4. When reporting explicitly on the change of HDX in a pep-
tide owing to, for example, the presence of a binding partner, 
a peptide uptake plot should be provided, plotting each labe-
ling time with the per-peptide standard deviation. Appro-
priate statistical analyses should be applied to all reports of 
differences between states. Furthermore, HDX information 
from multiple charge states and overlapping peptides should 
be used to add certainty to any conclusions.
2.5. A common data presentation format for HDX-MS data 
involves color-mapping the time-resolved, peptide-resolu-
tion data onto three-dimensional, static, atomic-resolution 
structures. Inappropriate mapping can result in a loss of 
information. When mapping HDX data onto structures, 
scientists should explicitly state their mapping methodology 
and at which time points data are depicted, and this approach 
should be based on a quantitative and statistical argument 
that is applied to the entire dataset. Such an encompassing 
method avoids selective presentation and permits a balanced 
assessment of biologically relevant findings. In cases where 
a difference in HDX is mapped, regions should be carefully 
indicated for which there is no sequence coverage. Further-
more, regions that exhibit ‘no significant difference’ should 
not be interpreted as ‘no change’. Rather, it means no detect-
able difference within the kinetic regime had been detected. 
Table 1 | HDX data summary
Dataset Protein state (one column for each condition: that is, apo, ligand-bound, mutant and others)
HDX reaction details Labeling conditions, for example, percent D2O, pH(read), temperature and so on
HDX time course Listing of what time points were analyzed
HDX controls Description of HDX control samples analyzed
Back-exchange Back-exchange (average) for all peptides measured (model system or studied protein) and the interquartile 
range of these values
Number of peptides Description of the number of peptides used for which HDX data were obtained
Sequence coverage Expressed as the percentage of amides covered by the peptides for which HDX data were obtained
Average peptide length/redundancy Average peptide length and number of readings for any amide (calculated as the total number of peptides for 
which HDX data were obtained over the total number of amides)
Replicates (biological or technical) Number and specification of replicate HDX-MS measurements performed for each condition and deuterium 
incorporation time point
Repeatability A quantitative measure of the repeatability of deuterium measurement (for example, the average standard 
deviation from technical replicate measurements of the deuterium content of all peptides from one or more 
time points for a single condition)
Significant differences in HDX A value used as a threshold to represent a significant difference in HDX between examined protein states as 
based on a quantitative measure of repeatability
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The mapping should be accompanied with an explicit state-
ment of this nature. Finally, both authors and readers must 
recognize that imposing HDX-MS results (measured in a 
dynamic solution-phase environment) on static structures 
can easily bias interpretation of the results. Two very different 
biophysical measurements are being combined, so it is dif-
ficult to convey the magnitude of conformational change on 
a single static structure. Interpretation is most accurate when 
based on HDX uptake plots.
 3. Supplemental data presentation recommendations
3.1. A supplementary ‘HDX data’ table corresponding to all 
the peptides included in the study, including peptides that 
show no significant difference between states, should be 
presented. Two examples of such a table are shown in Sup-
plementary Tables 2 and 3; either can be used depending on 
the output format of the HDX-MS data analysis software in 
use. We include these downloadable template spreadsheets 
to encourage the community to include such data in their 
reporting and to do so using this standardized and read-
ily accessible format. The HDX data table greatly simpli-
fies access to the acquired data for other scientists and will 
enable any downstream data processing, including use of the 
data for computational modeling. The minimum require-
ments are peptide sequence (start and end numbering and 
sequence), peptide monoisotopic mass (uncharged), chro-
matographic retention time, mean deuterium uptake (shift 
in average/centroid mass, without any correction for back-
exchange) and the standard deviation, for each labeling time, 
with a clear indication of the number (n) and nature of rep-
licates (technical/biological) used to determine this value. 
These data should be provided for all states measured (for 
example, apo and with a binding partner). If a maximally 
labeled control and quench exchange control samples are 
analyzed, similar data should be reported for these as well.
3.2. Provided that an HDX summary table (Table 1) and an HDX 
data table (Supplementary Tables 2 and 3) are provided, only 
deuterium uptake plots for peptides that are explicitly refer-
enced within the main body of the manuscript are necessary 
to include (in the manuscript or supplementary informa-
tion). These plots should show the appropriate deuteration 
values across all measured labeling times, with standard 
deviations between technical repeats indicated.
3.3. For peptides undergoing substantial EX1 or mixed 
exchange profiles56, we recommend the inclusion of raw 
deuterium incorporation mass spectra, or the use of deu-
terium incorporation plots that show the different bimodal 
populations (bubble plots can be a useful data representa-
tion for this type of data; see ref. 57).
Conclusion
The objective of our recommendations is to increase the transparency 
and utility of HDX-MS analyses for the reader, the wider community, 
the reviewer and the experimentalist. We recognize that these recom-
mendations are not exhaustive and should be viewed as a consensus-
based first iteration of a continuously evolving system of community 
self-review. One of the most pressing future steps is to agree to a 
standardized data structure that can be archived, retrieved and anno-
tated on an open data server. There is no agreed-upon mechanism for 
making published data readily available to interested parties, and we 
are not entirely convinced that co-opting proteomics repositories is 
the best strategy. As a first step to address this issue, we recommend 
including the ‘HDX summary’ table and also the ‘HDX data’ table 
as described here, in future publications of HDX-MS studies. We 
recommend including the following sentence in methods section of 
all papers: “To allow access to the HDX data of this study, the HDX 
data summary table (Table X) and the HDX data table (Table Y) are 
included in the supporting information as per consensus guidelines 
(with a reference to this manuscript).” We also recommend that raw 
HDX-MS data be made available for reanalysis to interested parties 
through personal file sharing whenever possible, until a standardized 
structure for raw data and an open data server for annotated HDX-MS 
data have been agreed upon or established by the community.
The development of a standardized approach for reporting of 
HDX data has major advantages in increasing the quality of pub-
lished HDX-MS data. First, the current disparity in published 
manuscripts as to what data are presented, and how these data are 
presented, can make reviewing and assessing HDX-MS experiments 
challenging. Second, certain key statistics and metrics that may 
affect the validity of the publication’s conclusions are sometimes 
reported in supplementary data or not mentioned at all. Third, 
there are enormous unexplored opportunities associated with meta-
analyses of archived HDX-MS data. Access to large sets of raw data 
could provide insights into the mechanism underlying the HDX 
process—a phenomenon still not completely understood—and fur-
thermore improve the utility of HDX-MS data for computational 
modeling of protein structures. Finally, a shared database would 
avoid unnecessary repetition of experiments. We believe that our 
recommendation to include both ‘HDX summary’ and ‘HDX data’ 
tables as described above would greatly facilitate upload and storage 
of HDX-MS data in a central community-accessible database.
Received: 13 February 2019; Accepted: 23 May 2019;  
Published online: 27 June 2019
References
 1. Weis, D. D. Hydrogen Exchange Mass Spectrometry of Proteins (John Wiley & 
Sons, 2016).
 2. Konermann, L., Pan, J. & Liu, Y.-H. Hydrogen exchange mass spectrometry for 
studying protein structure and dynamics. Chem. Soc. Rev. 40, 1224–1234 (2011).  
An excellent tutorial review of protein HDX and HDX-MS methodology.
 3. Hvidt, A. & Nielsen, S. O. Hydrogen exchange in proteins. Adv. Protein Chem. 
21, 287–386 (1966).
 4. Englander, S. W. & Kallenbach, N. R. Hydrogen exchange and structural 
dynamics of proteins and nucleic acids. Q. Rev. Biophys. 16, 521–655 (1983).  
A must-read review on the fundamentals of peptide HDX chemistry and 
how protein conformation, hydrogen-bonding and dynamics impact HDX.
 5. Trabjerg, E., Nazari, Z. E. & Rand, K. D. Conformational analysis of complex 
protein states by hydrogen/deuterium exchange mass spectrometry 
(HDX-MS): challenges and emerging solutions. TrAC Trends Anal. Chem. 
106, 125–138 (2018).
 6. Harrison, R. A. & Engen, J. R. Conformational insight into multi-protein 
signaling assemblies by hydrogen-deuterium exchange mass spectrometry. 
Curr. Opin. Struct. Biol. 41, 187–193 (2016).
 7. Chalmers, M. J., Busby, S. A., Pascal, B. D., West, G. M. & Griffin, P. R. 
Differential hydrogen/deuterium exchange mass spectrometry analysis of 
protein-ligand interactions. Expert Rev. Proteom. 8, 43–59 (2011).  
An excellent review of the use of HDX-MS to study protein–ligand 
interactions, and one of the first reviews to discuss and exemplify the 
importance of replicate and statistical analysis of HDX-MS data.
 8. Englander, J. J. et al. Protein structure change studied by hydrogen-deuterium 
exchange, functional labeling, and mass spectrometry. Proc. Natl Acad. Sci. 
USA 100, 7057–7062 (2003).
 9. Englander, S. W. & Mayne, L. The nature of protein folding pathways. Proc. 
Natl Acad. Sci. USA 111, 15873–15880 (2014).
 10. Balasubramaniam, D. & Komives, E. A. Hydrogen-exchange mass 
spectrometry for the study of intrinsic disorder in proteins. Biochim. Biophys. 
Acta 1834, 1202–1209 (2013).
 11. Vadas, O., Jenkins, M. L., Dornan, G. L. & Burke, J. E. Using hydrogen-
deuterium exchange mass spectrometry to examine protein-membrane 
interactions. Methods Enzymol. 583, 143–172 (2017).
 12. Deng, B., Lento, C. & Wilson, D. J. Hydrogen deuterium exchange mass 
spectrometry in biopharmaceutical discovery and development—a review. 
Anal. Chim. Acta 940, 8–20 (2016).
 13. Marciano, D. P., Dharmarajan, V. & Griffin, P. R. HDX-MS guided drug 
discovery: small molecules and biopharmaceuticals. Curr. Opin. Struct. Biol. 
28, 105–111 (2014).
 14. Hvidt, A. & Linderstrøm-Lang, K. Exchange of hydrogen atoms in insulin 
with deuterium atoms in aqueous solutions. Biochim. Biophys. Acta 14, 
574–575 (1954).
NATURE METHoDS | VOL 16 | JULY 2019 | 595–602 | www.nature.com/naturemethods 601
PersPective NATurE METHoDS
 15. Englander, S. W., Mayne, L., Bai, Y. & Sosnick, T. R. Hydrogen exchange: the 
modern legacy of Linderstrom-Lang. Protein Sci. 6, 1101–1109 (1997).
 16. Englander, S. W., Sosnick, T. R., Englander, J. J. & Mayne, L. Mechanisms and 
uses of hydrogen exchange. Curr. Opin. Struct. Biol. 6, 18–23 (1996).
 17. Johnson, R. S. & Walsh, K. A. Mass spectrometric measurement of protein 
amide hydrogen exchange rates of apo- and holo-myoglobin. Protein Sci. 3, 
2411–2418 (1994).
 18. Zhang, Z. & Smith, D. L. Determination of amide hydrogen exchange by 
mass spectrometry: a new tool for protein structure elucidation. Protein Sci. 
2, 522–531 (1993).
 19. Smith, D. L., Deng, Y. & Zhang, Z. Probing the non-covalent structure of 
proteins by amide hydrogen exchange and mass spectrometry. J. Mass 
Spectrom. 32, 135–146 (1997).  
An excellent early review of both key theoretical and practical aspects of 
the bottom-up HDX-MS workflow.
 20. Rey, M. et al. Mass spec studio for integrative structural biology. Structure 22, 
1538–1548 (2014).
 21. Wales, T. E., Eggertson, M. J. & Engen, J. R. Considerations in the analysis of 
hydrogen exchange mass spectrometry data. Methods Mol. Biol. 1007, 
263–288 (2013).
 22. Pascal, B. D. et al. HDX workbench: software for the analysis of H/D 
exchange MS data. J. Am. Soc. Mass Spectrom. 23, 1512–1521 (2012).
 23. Pirrone, G. F., Iacob, R. E. & Engen, J. R. Applications of hydrogen/deuterium 
exchange MS from 2012 to 2014. Anal. Chem. 87, 99–118 (2015).
 24. Hamdi, K. et al. Structural disorder and induced folding within two cereal, 
ABA stress and ripening (ASR) proteins. Sci. Rep. 7, 15544 (2017).
 25. Baños-Mateos, S. et al. High-fidelity DNA replication in Mycobacterium 
tuberculosis relies on a trinuclear zinc center. Nat. Commun. 8, 855 (2017).
 26. Lim, X.-X. et al. Epitope and paratope mapping reveals temperature-dependent 
alterations in the dengue-antibody interface. Structure 25, 1391–1402 (2017).
 27. Masson, G. R., Maslen, S. L. & Williams, R. L. Analysis of phosphoinositide 
3-kinase inhibitors by bottom-up electron-transfer dissociation hydrogen/
deuterium exchange mass spectrometry. Biochem. J. 474, 1867–1877 (2017).
 28. Merkle, P. S. et al. Substrate-modulated unwinding of transmembrane helices 
in the NSS transporter LeuT. Sci. Adv. 4, eaar6179 (2018).
 29. Lee, S. et al. Allosteric inhibition of antiapoptotic MCL-1. Nat. Struct. Mol. 
Biol. 23, 600–607 (2016).
 30. Shukla, A. K. et al. Visualization of arrestin recruitment by a G-protein-
coupled receptor. Nature 512, 21–222 (2014).
 31. Adams, R. et al. Discovery of a junctional epitope antibody that stabilizes 
IL-6 and gp80 protein:protein interaction and modulates its downstream 
signaling. Sci. Rep. 7, 37716 (2017).
 32. Rostislavleva, K. et al. Structure and flexibility of the endosomal Vps34 complex 
reveals the basis of its function on membranes. Science 350, aac7365 (2015).
 33. de Vera, I. M. S. et al. Synergistic regulation of coregulator/nuclear receptor 
interaction by ligand and DNA. Structure 25, 1506–1518 (2017).
 34. Moroco, J. A. & Engen, J. R. Replication in bioanalytical studies with HDX 
MS: aim as high as possible. Bioanalysis 7, 1065–1067 (2015).
 35. Iacob, R. E. & Engen, J. R. Hydrogen exchange mass spectrometry: are we out 
of the quicksand? J. Am. Soc. Mass Spectrom. 23, 1003–1010 (2012).
 36. Bennett, M. J., Barakat, K., Huzil, J. T., Tuszynski, J. & Schriemer, D. C. 
Discovery and characterization of the laulimalide-microtubule binding mode 
by mass shift perturbation mapping. Chem. Biol. 17, 725–734 (2010).
 37. Engen, J. R. & Wales, T. E. Analytical aspects of hydrogen exchange mass 
spectrometry. Annu. Rev. Anal. Chem. 8, 127–148 (2015).  
An excellent review of the specific analytical aspects of performing and 
interpreting data from HDX-MS experiments.
 38. Svensson, L. A. et al. Crystal structure of a prolactin receptor antagonist 
bound to the extracellular domain of the prolactin receptor. J. Biol. Chem. 
283, 19085–19094 (2008).
 39. Lim, X.-X. et al. Conformational changes in intact dengue virus reveal 
serotype-specific expansion. Nat. Commun. 8, 14339 (2017).
 40. Pacholarz, K. J. et al. Hybrid mass spectrometry approaches to determine 
how L-histidine feedback regulates the enzyzme mtatp-
phosphoribosyltransferase. Structure 25, 730–738.e4 (2017).
 41. van de Waterbeemd, M. et al. Structural analysis of a temperature-induced 
transition in a viral capsid probed by HDX-MS. Biophys. J. 112,  
1157–1165 (2017).
 42. Adhikary, S. et al. Conformational dynamics of a neurotransmitter:sodium 
symporter in a lipid bilayer. Proc. Natl Acad. Sci. USA 114, E1786–E1795 (2017).
 43. Burke, J. E. et al. Structures of PI4KIIIβ complexes show simultaneous 
recruitment of Rab11 and its effectors. Science 344, 1035–1038 (2014).
 44. Pantazatos, D. et al. Rapid refinement of crystallographic protein construct 
definition employing enhanced hydrogen/deuterium exchange MS. Proc. Natl 
Acad. Sci. USA 101, 751–756 (2004).
 45. Wales, T. E. & Engen, J. R. Hydrogen exchange mass spectrometry for the 
analysis of protein dynamics. Mass Spectrom. Rev. 25, 158–170 (2006).
 46. Pan, J., Han, J., Borchers, C. H. & Konermann, L. Hydrogen/deuterium 
exchange mass spectrometry with top-down electron capture dissociation for 
characterizing structural transitions of a 17 kDa protein. J. Am. Chem. Soc. 
131, 12801–12808 (2009).
 47. Rand, K. D., Adams, C. M., Zubarev, R. A. & Jørgensen, T. J. D. Electron 
capture dissociation proceeds with a low degree of intramolecular migration 
of peptide amide hydrogens. J. Am. Chem. Soc. 130, 1341–1349 (2008).
 48. Rand, K. D., Zehl, M., Jensen, O. N. & Jørgensen, T. J. D. Protein hydrogen 
exchange measured at single-residue resolution by electron transfer 
dissociation mass spectrometry. Anal. Chem. 81, 5577–5584 (2009).
 49. Abzalimov, R. R., Kaplan, D. A., Easterling, M. L. & Kaltashov, I. A. Protein 
conformations can be probed in top-down HDX MS experiments utilizing 
electron transfer dissociation of protein ions without hydrogen scrambling.  
J. Am. Soc. Mass Spectrom. 20, 1514–1517 (2009).
 50. Mistarz, U. H., Brown, J. M., Haselmann, K. F. & Rand, K. D. Simple setup 
for gas-phase H/D exchange mass spectrometry coupled to electron transfer 
dissociation and ion mobility for analysis of polypeptide structure on a liquid 
chromatographic time scale. Anal. Chem. 86, 11868–11876 (2014).
 51. Slysz, G. W., Percy, A. J. & Schriemer, D. C. Restraining expansion of the peak 
envelope in H/D exchange-MS and its application in detecting perturbations 
of protein structure/dynamics. Anal. Chem. 80, 7004–7011 (2008).
 52. Harrison, R. A. et al. Structural dynamics in Ras and related proteins upon 
nucleotide switching. J. Mol. Biol. 428, 4723–4735 (2016).
 53. Hoofnagle, A. N., Resing, K. A. & Ahn, N. G. Practical methods for deuterium 
exchange/mass spectrometry. Methods Mol. Biol. 250, 283–298 (2004).
 54. Miyagi, M. & Nakazawa, T. Determination of pKa values of individual 
histidine residues in proteins using mass spectrometry. Anal. Chem. 80, 
6481–6487 (2008).
 55. Wlodawer, A., Minor, W., Dauter, Z. & Jaskolski, M. Protein crystallography 
for non-crystallographers, or how to get the best (but not more) from 
published macromolecular structures. FEBS J. 275, 1–21 (2008).
 56. Sarpe, V. & Schriemer, D. C. Data processing in bottom‐up hydrogen 
exchange mass spectrometry. In Hydrogen Exchange Mass Spectrometry of 
Proteins: Fundamentals, Methods, and Applications (ed. Weis, D. D.) 37–53 
(John Wiley & Sons, 2016).
 57. Guttman, M., Weis, D. D., Engen, J. R. & Lee, K. K. Analysis of overlapped 
and noisy hydrogen/deuterium exchange mass spectra. J. Am. Soc. Mass 
Spectrom. 24, 1906–1912 (2013).
 58. Lee, J. et al. Crystal structure of the PTEN tumor suppressor: implications for 
its phosphoinositide phosphatase activity and membrane association. Cell 99, 
323–334 (1999).
Acknowledgements
There are numerous people who contributed to this document, and we thank the 
community as a whole for helping to sculpt the manuscript. We note the many 
participants in the discussions held at the IC-HDX conference (Gothenburg, Sweden, 
2017) who helped form the initial draft. We are grateful for the comments from 
academics, vendors, commercial scientists, and sponsors who participated in these 
discussions. We thank I. Møller and E. Trabjerg for assistance with administrative tasks 
and data formatting. This study was in part facilitated and funded by the EU COST 
Action BM1403 (Native Mass Spectrometry and Related Methods for Structural Biology).
Author contributions
G.R.M., J.E.B., D.C.S. and K.D.R. guided the development, writing and final edits. All 
authors contributed equally to the work.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/
s41592-019-0459-y.
Reprints and permissions information is available at www.nature.com/reprints.
Correspondence should be addressed to G.R.M., J.E.B., D.C.S. or K.D.R.
Peer review information: Allison Doerr was the primary editor on this article and managed 
its editorial process and peer review in collaboration with the rest of the editorial team.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in 
published maps and institutional affiliations.
© Springer Nature America, Inc. 2019
Open Access This article is licensed under a Creative Commons 
Attribution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long as 
you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made. The images or other third 
party material in this article are included in the article’s Creative Commons license, unless 
indicated otherwise in a credit line to the material. If material is not included in the article’s 
Creative Commons license and your intended use is not permitted by statutory regulation or 
exceeds the permitted use, you will need to obtain permission directly from the copyright 
holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
NATURE METHoDS | VOL 16 | JULY 2019 | 595–602 | www.nature.com/naturemethods602
